Kenryu Nishiyama - Concepedia

Author

Kenryu Nishiyama

Also Known As

K Nishiyama, K Nishiyama- (, K. Nishiyama, K. Nishiyama, KENRYU NISHIYAMA, Kaoru Nishiyama, Kenryu NISHIYAMA, Kenryu Nishiyama

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

Kagoshima University Chiba University National Cancer Institute Oita University Molecular Oncology (United States)

About

Kenryu Nishiyama is an author at Kagoshima University specializing in medicine, urology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	18	2.1K
2	Cell Biology	9	9	970
3	Natural Sciences	2	2	603
4	Biochemistry	2	2	603
5	Cellular Physiology	1	1	261

Kenryu Nishiyama

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Identification of novel microRNA targets based on microRNA signatures in bladder cancer Takahiro Ichimi, Hideki Enokida, Yasushi Okuno, International Journal of Cancer Microrna SignaturesUrologyOncologyTarget Search AlgorithmGenitourinary Cancer	2009	401
Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells. Robert W. Robey, W Y Medina-Pérez, Kenryu Nishiyama, PubMed Chemoprevention StrategyAtp-binding Cassette Half-transporterCancer BiologyTumor BiologyDrug Resistance	2001	342
miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer Takeshi Chiyomaru, Hideki Enokida, Shuichi Tatarano, British Journal of Cancer	2010	329
The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer Hirofumi Yoshino, Takeshi Chiyomaru, Hideki Enokida, British Journal of Cancer	2011	277
Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells. Mariafiorella Brangi, Thomas Litman, Marco Ciotti, PubMed Intrinsic Drug ResistanceCellular PharmacologyCancer BiologyRedox BiologyCellular Physiology	1999	261
MiR‐96 and miR‐183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology Yasutoshi Yamada, Hideki Enokida, Satoko Kojima, Cancer Science Urological ResearchUrologyOncologyGenitourinary CancerUc Detection	2010	216
Prognosis of Japanese Metastatic Renal Cell Carcinoma Patients in the Cytokine Era: A Cooperative Group Report of 1463 Patients Sei Naito, Naoki Yamamoto, Tatsuya Takayama, European Urology UrologyGenitourinary CancerMedicineRenal PathologyRenal Inflammation	2009	193
The functional significance of miR-1 and miR-133a in renal cell carcinoma Kazumori Kawakami, Hideki Enokida, Takeshi Chiyomaru, European Journal of Cancer Tumor BiologyUrologyGenitourinary CancerMedicineRenal Pathology	2011	148
Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer Takeshi Chiyomaru, Hideki Enokida, Kazumori Kawakami, Urologic Oncology Seminars and Original Investigations MedicineFunctional RoleCell ViabilityCell BiologyTumor Suppressor	2010	118
Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma. Y Imazano, Yuji Takebayashi, Kenryu Nishiyama, Journal of Clinical Oncology	1997	104

Page 1